SN

Shivraj Narayanrao Chilwant

Active Director Director DIN 09252927
DIN 09252927 First appointment Jul 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivraj Narayanrao Chilwant

Data last updated:

Shivraj Narayanrao Chilwant is a Director at Indic Pharma Private Limited (since 2021). The company operates in Pharma.

DIN 09252927
Primary Designation Director
Industry Pharma
First Appointment 23 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indic Pharma Private Limited U24232MH2021PTC364556
Director23 Jul 20212021Active

Board colleagues of Shivraj Narayanrao Chilwant

NameDINCompanyDesignation
Pralhad Govind Dharurkar09252926Indic Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indic Pharma Private Limited
Premium access

Shareholding and investment profile for Shivraj Narayanrao Chilwant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivraj Narayanrao Chilwant

Shivraj Narayanrao Chilwant currently holds 1 directorship: Indic Pharma Private Limited (Director, since 23 Jul 2021).

Shivraj Narayanrao Chilwant was first appointed on 23 Jul 2021 as Director at Indic Pharma Private Limited.

The current boards of Shivraj Narayanrao Chilwant's companies include Pralhad Govind Dharurkar (Indic Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available